Best for
Mobile
How to buy PRA Health Sciences shares
Own PRA Health Sciences shares in just a few minutes.
PRA Health Sciences, Inc is a diagnostics & research business based in the US. PRA Health Sciences shares (PRAH.US) are listed on the NASDAQ and all prices are listed in US Dollars. PRA Health Sciences employs 17,500 staff and has a trailing 12-month revenue of around $3.1 billion.
How to buy shares in PRA Health Sciences
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PRAH in this case.
- Research PRA Health Sciences shares. The platform should provide the latest information available.
- Buy your PRA Health Sciences shares. It's that simple.
What's in this guide?
- Can I buy shares in PRA Health Sciences?
- PRA Health Sciences shares summary
- Compare share dealing platforms
- Is PRA Health Sciences stock a buy or sell?
- Can I short PRA Health Sciences shares?
- Are PRA Health Sciences shares over-valued?
- PRA Health Sciences's financials
- How volatile are PRA Health Sciences shares?
- Does PRA Health Sciences pay a dividend?
- Other common questions
PRA Health Sciences share price
Use our graph to track the performance of PRAH stocks over time.PRA Health Sciences shares at a glance
Information last updated 2021-01-23.
| Latest market close | $N/A |
|---|---|
| 52-week range | $58.67 - $137.88 |
| 50-day moving average | $123.5818 |
| 200-day moving average | $109.4601 |
| Wall St. target price | $126.75 |
| PE ratio | 38.7065 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $3.417 |
Invest in PRA Health Sciences shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy PRA Health Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is PRA Health Sciences under- or over-valued?
Valuing PRA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PRA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PRA Health Sciences's P/E ratio
PRA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, PRA Health Sciences shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PRA Health Sciences's PEG ratio
PRA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5218. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PRA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PRA Health Sciences's EBITDA
PRA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $417 million.
The EBITDA is a measure of a PRA Health Sciences's overall financial performance and is widely used to measure a its profitability.
PRA Health Sciences financials
| Revenue TTM | $3.1 billion |
|---|---|
| Operating margin TTM | 9.31% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 4.93% |
| Return on equity TTM | 19.42% |
| Profit margin | 7.09% |
| Book value | $20.675 |
| Market capitalisation | $8.5 billion |
TTM: trailing 12 months
How to short and sell PRA Health Sciences shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PRAH.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 972,689 PRA Health Sciences shares held short by investors – that's known as PRA Health Sciences's "short interest". This figure is 4% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting PRA Health Sciences shares can be evaluated.
PRA Health Sciences's "short interest ratio" (SIR)
PRA Health Sciences's "short interest ratio" (SIR) is the quantity of PRA Health Sciences shares currently shorted divided by the average quantity of PRA Health Sciences shares traded daily (recently around 276332.10227273). PRA Health Sciences's SIR currently stands at 3.52. In other words for every 100,000 PRA Health Sciences shares traded daily on the market, roughly 3520 shares are currently held short.
However PRA Health Sciences's short interest can also be evaluated against the total number of PRA Health Sciences shares, or, against the total number of tradable PRA Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PRA Health Sciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 PRA Health Sciences shares in existence, roughly 20 shares are currently held short) or 0.0222% of the tradable shares (for every 100,000 tradable PRA Health Sciences shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PRA Health Sciences.
Find out more about how you can short PRA Health Sciences stock.
PRA Health Sciences share dividends
We're not expecting PRA Health Sciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
PRA Health Sciences share price volatility
Over the last 12 months, PRA Health Sciences's shares have ranged in value from as little as $58.67 up to $137.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PRA Health Sciences's is 1.2437. This would suggest that PRA Health Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
PRA Health Sciences overview
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company has a partnership with The Leukemia & Lymphoma Society to launch a clinical trial for developing treatments for children with relapsed acute leukemia. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
Frequently asked questions
More guides on Finder
-
How to buy PRA Health Sciences shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy PRA Health Sciences shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert